FDA Approves Brexafemme For Recurrent Yeast InfectionsThe Food and Drug Administration (FDA) has approved Brexafemme (ibrexafungerp) for a second indication for reduction in incidence of recurrent…
Clinical presentation, diagnosis, and management of Mycoplasma genitaliumIn 2015, the Centers for Disease Control and Prevention (CDC) announced that Mycoplasma genitalium was a public health threat.1 Other…
Deadly fungus Candida auris is spreading across US hospitals – a physician answers 5 questions about rising fungal infectionsIn late March 2023, the U.S. Centers for Disease Control and Prevention highlighted the threat posed by a rapidly spreading…
STD resources for testing, diagnosing and treating sexually transmitted infectionsOne in five people had a sexually transmitted disease (STD) in 2018, the CDC estimates, adding that the number continued…
Clinical presentation, diagnosis, and management of Mycoplasma genitaliumJessica N. Wellette, DNP, APRN, WHNP-BC; Shelza J. Rivas, DNP, APRN, WHNP-BC, AGPCNP-BC; and Melissa G. Davis, DNP, CNM, FNP-BC, FACNM, C-EFM
Deadly fungus Candida auris is spreading across US hospitals – a physician answers 5 questions about rising fungal infectionsArif R. Sarwari, West Virginia University